Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

White Noise Speech Illusions: A Trait-Dependent Risk Marker for Psychotic Disorder?

Schepers E, Lousberg R, Guloksuz S, Pries LK, Delespaul P, Kenis G, Luykx JJ, Lin BD, Richards AL, Akdede B, Binbay T, Altınyazar V, Yalınçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Şahin Cankurtaran E, Ulusoy Kaymak S, Mihaljevic MM, Andric Petrovic S, Mirjanic T, Bernardo M, Cabrera B, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Luis Santos J, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşoğlu C, Ucok A, Alptekin K, Can Saka M, Arango C, Rutten BPF, van Os J.

Front Psychiatry. 2019 Sep 25;10:676. doi: 10.3389/fpsyt.2019.00676. eCollection 2019.

2.

Relationship Between Cognitive-Behavioral Impairment and Clinical and Functional Parameters in ALS and Reliability of the Edinburgh Cognitive and Behavioural ALS Screen to Assess ALS: Preliminary Findings.

Díaz JL, Mondragón H, Sancho J, Aguilar EJ, Servera E.

Cogn Behav Neurol. 2019 Sep;32(3):185-192. doi: 10.1097/WNN.0000000000000199.

PMID:
31517702
3.

Estimating Exposome Score for Schizophrenia Using Predictive Modeling Approach in Two Independent Samples: The Results From the EUGEI Study.

Pries LK, Lage-Castellanos A, Delespaul P, Kenis G, Luykx JJ, Lin BD, Richards AL, Akdede B, Binbay T, Altinyazar V, Yalinçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Cankurtaran EŞ, Kaymak SU, Mihaljevic MM, Petrovic SA, Mirjanic T, Bernardo M, Cabrera B, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Santos JL, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşoğlu C, Ucok A, Alptekin K, Saka MC; Genetic Risk and Outcome of Psychosis (GROUP) investigators, Arango C, O'Donovan M, Rutten BPF, van Os J, Guloksuz S.

Schizophr Bull. 2019 Sep 11;45(5):960-965. doi: 10.1093/schbul/sbz054.

PMID:
31508804
4.

Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression.

Aguilar EJ, Ricciuti B, Gainor JF, Kehl KL, Kravets S, Dahlberg S, Nishino M, Sholl LM, Adeni A, Subegdjo S, Khosrowjerdi S, Peterson RM, Digumarthy S, Liu C, Sauter J, Rizvi H, Arbour KC, Carter BW, Heymach JV, Altan M, Hellmann MD, Awad MM.

Ann Oncol. 2019 Oct 1;30(10):1653-1659. doi: 10.1093/annonc/mdz288.

PMID:
31435660
5.

The development of psychosomatic and Liaison Psychiatry units in Spain: A national enquiry.

Lobo A, Rabanaque I, Blanch J, Campos R, Ezquiaga E, Farré JM, Gómez-Reino I, Marco C, Navío M, Ochoa E, Parramón G, Ventura T, Aguilar EJ, Artal J, Cuesta M, Devolx VM, Espárrago G, Franco MA, Hernández Fleta JL, Martínez Jambrina JJ, Ortega MÁ, Palomo J, Pérez Costillas L, Roca M.

J Psychosom Res. 2019 Oct;125:109784. doi: 10.1016/j.jpsychores.2019.109784. Epub 2019 Jul 26. No abstract available.

PMID:
31421327
6.

Replicated evidence that endophenotypic expression of schizophrenia polygenic risk is greater in healthy siblings of patients compared to controls, suggesting gene-environment interaction. The EUGEI study.

van Os J, Pries LK, Delespaul P, Kenis G, Luykx JJ, Lin BD, Richards AL, Akdede B, Binbay T, Altınyazar V, Yalınçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Cankurtaran EŞ, Kaymak SU, Mihaljevic MM, Petrovic SA, Mirjanic T, Bernardo M, Cabrera B, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Santos JL, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşoğlu C, Ucok A, Alptekin K, Saka MC; Genetic Risk and Outcome Investigators (GROUP), Arango C, O'Donovan M, Rutten BPF, Guloksuz S.

Psychol Med. 2019 Aug 15:1-14. doi: 10.1017/S003329171900196X. [Epub ahead of print]

PMID:
31414981
7.

Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study.

Guloksuz S, Pries LK, Delespaul P, Kenis G, Luykx JJ, Lin BD, Richards AL, Akdede B, Binbay T, Altınyazar V, Yalınçetin B, Gümüş-Akay G, Cihan B, Soygür H, Ulaş H, Cankurtaran E, Kaymak SU, Mihaljevic MM, Petrovic SA, Mirjanic T, Bernardo M, Cabrera B, Bobes J, Saiz PA, García-Portilla MP, Sanjuan J, Aguilar EJ, Santos JL, Jiménez-López E, Arrojo M, Carracedo A, López G, González-Peñas J, Parellada M, Maric NP, Atbaşog Lu C, Ucok A, Alptekin K, Saka MC; Genetic Risk and Outcome of Psychosis (GROUP) investigators, Arango C, O'Donovan M, Rutten BPF, van Os J.

World Psychiatry. 2019 Jun;18(2):173-182. doi: 10.1002/wps.20629.

8.

STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.

Skoulidis F, Goldberg ME, Greenawalt DM, Hellmann MD, Awad MM, Gainor JF, Schrock AB, Hartmaier RJ, Trabucco SE, Gay L, Ali SM, Elvin JA, Singal G, Ross JS, Fabrizio D, Szabo PM, Chang H, Sasson A, Srinivasan S, Kirov S, Szustakowski J, Vitazka P, Edwards R, Bufill JA, Sharma N, Ou SI, Peled N, Spigel DR, Rizvi H, Aguilar EJ, Carter BW, Erasmus J, Halpenny DF, Plodkowski AJ, Long NM, Nishino M, Denning WL, Galan-Cobo A, Hamdi H, Hirz T, Tong P, Wang J, Rodriguez-Canales J, Villalobos PA, Parra ER, Kalhor N, Sholl LM, Sauter JL, Jungbluth AA, Mino-Kenudson M, Azimi R, Elamin YY, Zhang J, Leonardi GC, Jiang F, Wong KK, Lee JJ, Papadimitrakopoulou VA, Wistuba II, Miller VA, Frampton GM, Wolchok JD, Shaw AT, Jänne PA, Stephens PJ, Rudin CM, Geese WJ, Albacker LA, Heymach JV.

Cancer Discov. 2018 Jul;8(7):822-835. doi: 10.1158/2159-8290.CD-18-0099. Epub 2018 May 17.

9.

Emotional fMR auditory paradigm demonstrates normalization of limbic hyperactivity after cognitive behavior therapy for auditory hallucinations.

Aguilar EJ, Corripio I, García-Martí G, Grasa E, Martí-Bonmatí L, Gómez-Ansón B, Sanjuán J, Núñez-Marín F, Lorente-Rovira E, Escartí MJ, Brabban A, Turkington D.

Schizophr Res. 2018 Mar;193:304-312. doi: 10.1016/j.schres.2017.07.024. Epub 2017 Jul 15. No abstract available.

PMID:
28720416
10.

A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project.

Bioque M, Llerena A, Cabrera B, Mezquida G, Lobo A, González-Pinto A, Díaz-Caneja CM, Corripio I, Aguilar EJ, Bulbena A, Castro-Fornieles J, Vieta E, Lafuente A, Mas S, Parellada M, Saiz-Ruiz J, Cuesta MJ, Bernardo M; PEPs GROUP.

Int J Neuropsychopharmacol. 2016 Mar 31;19(4). pii: pyv121. doi: 10.1093/ijnp/pyv121. Print 2016 Apr.

11.

Study of the inferior colliculus in patients with schizophrenia by magnetic resonance spectroscopy.

Martinez-Granados B, Martinez-Bisbal MC, Sanjuan J, Aguilar EJ, Marti-Bonmati L, Molla E, Celda B.

Rev Neurol. 2014 Jul 1;59(1):1-7. English, Spanish.

12.
13.

[Functional neuroimaging in the study of aggressive behaviour in patients with schizophrenia].

Garciá-Martí G, Martí-Bonmatí L, Aguilar EJ, Sanz-Requena R, Alberich-Bayarri Á, Bonmatí A, Sanjuán J.

Rev Neurol. 2013 Feb 16;56(4):193-9. Spanish.

14.

Multimodal morphometry and functional magnetic resonance imaging in schizophrenia and auditory hallucinations.

García-Martí G, Aguilar EJ, Martí-Bonmatí L, Escartí MJ, Sanjuán J.

World J Radiol. 2012 Apr 28;4(4):159-66. doi: 10.4329/wjr.v4.i4.159.

15.

[Magnetic resonance imaging postprocessing techniques in the study of brain connectivity].

de la Iglesia-Vayá M, Molina-Mateo J, Escarti-Fabra MJ, Martí-Bonmatí L, Robles M, Meneu T, Aguilar EJ, Sanjuán J.

Radiologia. 2011 May-Jun;53(3):236-45. doi: 10.1016/j.rx.2010.11.007. Epub 2011 Apr 7. Review. Spanish.

16.

Serotonin transporter gene polymorphisms and auditory hallucinations in psychosis.

Rivero O, Sanjuan J, Aguilar EJ, Gonzalez JC, Molto MD, de Frutos R, Najera C.

Rev Neurol. 2010 Mar 16;50(6):325-32. English, Spanish.

17.

Increased amygdala and parahippocampal gyrus activation in schizophrenic patients with auditory hallucinations: an fMRI study using independent component analysis.

Escartí MJ, de la Iglesia-Vayá M, Martí-Bonmatí L, Robles M, Carbonell J, Lull JJ, García-Martí G, Manjón JV, Aguilar EJ, Aleman A, Sanjuán J.

Schizophr Res. 2010 Mar;117(1):31-41. doi: 10.1016/j.schres.2009.12.028. Epub 2010 Jan 13.

PMID:
20071145
18.

[Emotional response to threatening stimuli in psychosis and anxiety disorders].

Luengo A, Lorente E, Herrero N, Aguilar EJ, Escartí MJ, González JC, Leal C, Sanjuán J.

Psicothema. 2009 Feb;21(1):51-6. Spanish.

PMID:
19178856
19.

Left orbitofrontal and superior temporal gyrus structural changes associated to suicidal behavior in patients with schizophrenia.

Aguilar EJ, García-Martí G, Martí-Bonmatí L, Lull JJ, Moratal D, Escartí MJ, Robles M, González JC, Guillamón MI, Sanjuán J.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Oct 1;32(7):1673-6. doi: 10.1016/j.pnpbp.2008.06.016. Epub 2008 Jul 11.

PMID:
18657587
20.

Spectroscopic metabolomic abnormalities in the thalamus related to auditory hallucinations in patients with schizophrenia.

Martínez-Granados B, Brotons O, Martínez-Bisbal MC, Celda B, Martí-Bonmati L, Aguilar EJ, González JC, Sanjuán J.

Schizophr Res. 2008 Sep;104(1-3):13-22. doi: 10.1016/j.schres.2008.05.025. Epub 2008 Jul 22.

PMID:
18650068
21.

MR and genetics in schizophrenia: focus on auditory hallucinations.

Aguilar EJ, Sanjuan J, García-Martí G, Lull JJ, Robles M.

Eur J Radiol. 2008 Sep;67(3):434-9. doi: 10.1016/j.ejrad.2008.02.046. Epub 2008 Apr 23. Review.

PMID:
18436404
22.

Do antipsychotic drugs influence suicidal behavior in schizophrenia?

Aguilar EJ, Siris SG.

Psychopharmacol Bull. 2007;40(3):128-42. Review.

PMID:
18007574
23.

Schizophrenia with auditory hallucinations: a voxel-based morphometry study.

García-Martí G, Aguilar EJ, Lull JJ, Martí-Bonmatí L, Escartí MJ, Manjón JV, Moratal D, Robles M, Sanjuán J.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):72-80. Epub 2007 Jul 19.

PMID:
17716795
24.

Chronic auditory hallucinations in schizophrenic patients: MR analysis of the coincidence between functional and morphologic abnormalities.

Martí-Bonmatí L, Lull JJ, García-Martí G, Aguilar EJ, Moratal-Pérez D, Poyatos C, Robles M, Sanjuán J.

Radiology. 2007 Aug;244(2):549-56.

PMID:
17641373
25.

Association between CCK-AR gene and schizophrenia with auditory hallucinations.

Toirac I, Sanjuán J, Aguilar EJ, González JC, Artigas F, Rivero O, Nájera C, Moltó MD, de Frutos R.

Psychiatr Genet. 2007 Apr;17(2):47-53.

PMID:
17413443
26.

Emotional words induce enhanced brain activity in schizophrenic patients with auditory hallucinations.

Sanjuan J, Lull JJ, Aguilar EJ, Martí-Bonmatí L, Moratal D, Gonzalez JC, Robles M, Keshavan MS.

Psychiatry Res. 2007 Jan 15;154(1):21-9. Epub 2006 Dec 20.

PMID:
17184978
27.

Are there subtypes of suicidal schizophrenia? A prospective study.

Acosta FJ, Aguilar EJ, Cejas MR, Gracia R, Caballero-Hidalgo A, Siris SG.

Schizophr Res. 2006 Sep;86(1-3):215-20. Epub 2006 Jul 13.

PMID:
16842974
28.

The microcephaly ASPM gene and schizophrenia: A preliminary study.

Rivero O, Sanjuán J, Moltó MD, Aguilar EJ, Gonzalez JC, de Frutos R, Nájera C.

Schizophr Res. 2006 Jun;84(2-3):427-9. Epub 2006 May 2. No abstract available.

PMID:
16631353
29.

Association between FOXP2 polymorphisms and schizophrenia with auditory hallucinations.

Sanjuán J, Tolosa A, González JC, Aguilar EJ, Pérez-Tur J, Nájera C, Moltó MD, de Frutos R.

Psychiatr Genet. 2006 Apr;16(2):67-72.

PMID:
16538183
30.

Persistent auditory hallucinations.

González JC, Aguilar EJ, Berenguer V, Leal C, Sanjuan J.

Psychopathology. 2006;39(3):120-5. Epub 2006 Mar 1.

PMID:
16531686
31.
32.

Subjective perception of cognitive deficit in psychotic patients.

Sanjuán J, Aguilar EJ, Olivares JM, Ros S, Montejo AL, Mayoral F, Gonzalez-Torres MA, Bousoño M.

J Nerv Ment Dis. 2006 Jan;194(1):58-60.

PMID:
16462557
33.

Time for a broad phenotype in schizophrenia?

Sanjuan J, Aguilar EJ, de Frutos R.

Br J Psychiatry. 2006 Feb;188:190. No abstract available.

PMID:
16449710
34.

Emotional auditory paradigm in neuroimaging: a base for the study of psychosis.

Sanjuán J, Lull JJ, Martí-Bonmati L, Aguilar EJ, Gadea M, Moratal-Pérez D, González JC, Robles M.

Actas Esp Psiquiatr. 2005 Nov-Dec;33(6):383-9.

PMID:
16292722
35.

Serotonin transporter gene polymorphism (5-HTTLPR) and emotional response to auditory hallucinations in schizophrenia.

Sanjuan J, Rivero O, Aguilar EJ, González JC, Moltó MD, de Frutos R, Lesch KP, Nájera C.

Int J Neuropsychopharmacol. 2006 Feb;9(1):131-3. Epub 2005 May 26. No abstract available.

PMID:
15916716
36.

FOXP2 polymorphisms in patients with schizophrenia.

Sanjuan J, Tolosa A, González JC, Aguilar EJ, Moltó MD, Nájera C, de Frutos R.

Schizophr Res. 2005 Mar 1;73(2-3):253-6.

PMID:
15653268
37.

Pleasurable auditory hallucinations.

Sanjuan J, Gonzalez JC, Aguilar EJ, Leal C, van Os J.

Acta Psychiatr Scand. 2004 Oct;110(4):273-8.

PMID:
15352928
38.

A graph model for the evolution of specificity in humoral immunity.

Flores LE, Aguilar EJ, Barbosa VC, de Carvalho LA.

J Theor Biol. 2004 Aug 7;229(3):311-25.

PMID:
15234199
39.

A psychopathological study of a group of schizophrenic patients after attempting suicide. Are there two different clinical subtypes?

Aguilar EJ, Leal C, Acosta FJ, Cejas MR, Fernández L, Gracia R.

Eur Psychiatry. 2003 Jun;18(4):190-2.

PMID:
12814854
40.

Knowledge and perception of risk for HIV and condom use among male injecting drug users in Cebu City, Philippines.

Amadora-Nolasco F, Alburo RE, Aguilar EJ, Trevathan WR.

Drug Alcohol Rev. 2002 Jun;21(2):137-43.

PMID:
12188992
41.

Hopelessness and first-episode psychosis: a longitudinal study.

Aguilar EJ, Haas G, Manzanera FJ, Hernández J, Gracia R, Rodado MJ, Keshavan MS.

Acta Psychiatr Scand. 1997 Jul;96(1):25-30.

PMID:
9259220
42.

Predictors of acute dystonia in first-episode psychotic patients.

Aguilar EJ, Keshavan MS, Martínez-Quiles MD, Hernández J, Gómez-Beneyto M, Schooler NR.

Am J Psychiatry. 1994 Dec;151(12):1819-21.

PMID:
7977894
43.

[Bullous eruption in systemic lupus erythematosus].

Wanke NC, Bruce MC, De Aguilar EJ, Pinto FM.

Med Cutan Ibero Lat Am. 1984;12(3):209-13. Portuguese.

PMID:
6384691

Supplemental Content

Loading ...
Support Center